SIRT7 Represses Myc Activity to Suppress ER Stress and Prevent Fatty Liver Disease by Shin Jiyung, He Ming, Liu Yufei, Paredes Silvana, Villanova Lidia, Brown Katharine, Qiu Xiaolei, Nabavi Noushin, Mohrin Mary, Wojnoonski Kathleen, Li Patrick, Cheng Hwei-Ling, Murphy Andrew J, Valenzuela David M, Luo Hanzhi, Kapahi Pankaj, Krauss Ronald, Mostoslavsky Raul, Yancopoulos George D, Alt Frederick W, Chua Katrin F, Chen Danica in Cell reports (2013).

[PMID: 24210820] PubMed


Nonalcoholic fatty liver disease is the most common chronic liver disorder in developed countries. Its pathogenesis is poorly understood, and therapeutic options are limited. Here, we show that SIRT7, an NAD(+)-dependent H3K18Ac deacetylase, functions at chromatin to suppress ER stress and prevent the development of fatty liver disease. SIRT7 is induced upon ER stress and is stabilized at the promoters of ribosomal proteins through its interaction with the transcription factor Myc to silence gene expression and to relieve ER stress. SIRT7-deficient mice develop chronic hepatosteatosis resembling human fatty liver disease. Myc inactivation or pharmacological suppression of ER stress alleviates fatty liver caused by SIRT7 deficiency. Importantly, SIRT7 suppresses ER stress and reverts the fatty liver disease in diet-induced obese mice. Our study identifies SIRT7 as a cofactor of Myc for transcriptional repression and delineates a druggable regulatory branch of the ER stress response that prevents and reverts fatty liver disease.

[ hide abstract ]

Discussed In Paper


Dosing Information

No dosing information annotated.